Use of Defibrotide to help prevent post-transplant endothelial injury in a genetically predisposed infant with metachromatic leukodystrophy undergoing hematopoietic stem cell gene therapy
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.